Brief: Epigenomics Q1 Net Loss At EUR -1.2 Mln
12/05/2021 07:12
May 12 (Reuters) - EPIGENOMICS AG ECXn.DE :
* REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2021
* Q1 NET LOSS -1.201 MILLION EUR VERSUS -2.982 MILLION EUR
LOSS
YEAR AGO
* PRODUCT REVENUE IN Q1 2021 DECREASED FROM EUR 239 THOUSAND
TO
EUR 106 THOUSAND COMPARED TO PRIOR-YEAR PERIOD
* CONFIRMS ITS OUTLOOK FOR FISCAL YEAR 2021
Source text for Eikon: ID:nEQ6MzgKJa
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns